These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15483771)

  • 1. [Anxiety and anxiety management in patients with implanted cardioverter-defibrillators].
    Ladwig KH; Wirsching C; V Hammerstein A; Danner R; Baumert J; Schmitt C
    Dtsch Med Wochenschr; 2004 Oct; 129(43):2311-5. PubMed ID: 15483771
    [No Abstract]   [Full Text] [Related]  

  • 2. The marriage of true minds: the partner of the ICD patient as a new focus for study.
    Newman D; Crystal E
    Pacing Clin Electrophysiol; 2010 Dec; 33(12):1427-9. PubMed ID: 20946277
    [No Abstract]   [Full Text] [Related]  

  • 3. Implantable cardioverter defibrillator (ICD) in children.
    Eicken A; Kolb C; Lange S; Brodherr-Heberlein S; Zrenner B; Schreiber C; Hess J
    Int J Cardiol; 2006 Feb; 107(1):30-5. PubMed ID: 16337494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of prophylactic implantable cardioverter defibrillators to prevent sudden cardiac death.
    Talajic M; Mitchell LB; Hadjis T
    Can J Cardiol; 2000 Jun; 16 Suppl C():26C-8C. PubMed ID: 10887275
    [No Abstract]   [Full Text] [Related]  

  • 5. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death.
    Stockburger M; Krebs A; Nitardy A; Habedank D; Celebi O; Knaus T; Dietz R
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S16-20. PubMed ID: 19250084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable cardioverter-defibrillators in patients with Chagas heart disease: misperceptions, many questions and the urgent need for a randomized clinical trial.
    Rassi A
    J Cardiovasc Electrophysiol; 2007 Dec; 18(12):1241-3. PubMed ID: 17971129
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness of implantable cardioverter-defibrillators.
    Boriani G; Biffi M; Martignani C; Gallina M; Branzi A
    Eur Heart J; 2001 Jun; 22(12):990-6. PubMed ID: 11428834
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy.
    Cardinalli-Neto A; Bestetti RB; Cordeiro JA
    J Cardiovasc Electrophysiol; 2008 Apr; 19(4):E34-5. PubMed ID: 18298517
    [No Abstract]   [Full Text] [Related]  

  • 10. Implantable cardioverter-defibrillator therapy after acute myocardial infarction: the results are not shocking.
    Goldberger JJ; Passman R
    J Am Coll Cardiol; 2009 Nov; 54(22):2001-5. PubMed ID: 19926004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethical issues with implantable defibrillators.
    Veenhuyzen GD; Simpson CS
    Pacing Clin Electrophysiol; 2005 Feb; 28(2):173-4; author reply 174. PubMed ID: 15679652
    [No Abstract]   [Full Text] [Related]  

  • 12. Ethical issues with implantable defibrillators.
    Brennan FJ
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):897-8. PubMed ID: 15271005
    [No Abstract]   [Full Text] [Related]  

  • 13. Comments on ethical issues with implantable defibrillators by F. James Brennan.
    Rahmoeller G
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):899. PubMed ID: 15271006
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of sudden cardiac death: the role of the implantable cardioverter-defibrillator.
    Sinha SK; Mehta D; Gomes JA
    Mt Sinai J Med; 2005 Jan; 72(1):1-9. PubMed ID: 15682255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity as a risk factor for sustained ventricular tachyarrhythmias in MADIT II patients.
    Pietrasik G; Goldenberg I; McNitt S; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2007 Feb; 18(2):181-4. PubMed ID: 17338766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A; Ghidina M
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
    [No Abstract]   [Full Text] [Related]  

  • 17. Quality of life and psychological status of patients with implantable cardioverter defibrillators.
    Thomas SA; Friedmann E; Kao CW; Inguito P; Metcalf M; Kelley FJ; Gottlieb SS
    Am J Crit Care; 2006 Jul; 15(4):389-98. PubMed ID: 16823016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials update: sudden cardiac death prevention by implantable device therapy.
    Finch NJ; Leman RB
    Crit Care Nurs Clin North Am; 2005 Mar; 17(1):33-8, x. PubMed ID: 15749399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wearable cardioverter-defibrillators.
    Adler A; Halkin A; Viskin S
    Circulation; 2013 Feb; 127(7):854-60. PubMed ID: 23429896
    [No Abstract]   [Full Text] [Related]  

  • 20. The riddle of nonsustained ventricular tachycardia and sudden cardiac death: are we approaching a solution?
    Patton KK
    Circulation; 2010 Aug; 122(5):449-51. PubMed ID: 20644012
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.